Prana Biotechnology Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
22.40
31.60
22.80
21.30
21.80
Gross Income
22.40
31.60
22.80
21.30
21.80
SG&A Expense
20,709.20
17,155.50
13,460.30
9,889.50
11,241.90
EBIT
20,731.60
17,187.10
13,483.20
9,910.90
11,263.70
Unusual Expense
30.20
86.30
-
-
-
Non Operating Income/Expense
704.10
4,950.00
857.30
786.30
329.00
Interest Expense
30.00
-
-
-
-
Pretax Income
21,132.20
11,974.00
12,483.20
10,564.70
11,391.50
Income Tax
7,802.90
6,088.90
4,753.70
3,022.70
3,125.80
Consolidated Net Income
13,329.20
5,885.10
7,729.60
7,542.10
8,265.70
Net Income
13,329.20
5,885.10
7,729.60
7,542.10
8,265.70
Net Income After Extraordinaries
13,329.20
5,885.10
7,729.60
7,542.10
8,265.70
Net Income Available to Common
13,329.20
5,885.10
7,729.60
7,542.10
8,265.70
EPS (Basic)
0.03
0.01
0.01
0.01
0.02
Basic Shares Outstanding
428,047.10
502,715.00
533,891.50
533,891.50
533,891.50
EPS (Diluted)
0.03
0.01
0.01
0.01
0.02
Diluted Shares Outstanding
428,047.10
502,715.00
533,891.50
533,891.50
533,891.50
EBITDA
20,709.20
17,155.50
13,460.30
9,889.50
11,241.90
Non-Operating Interest Income
363.80
176.80
142.70
132.40
201.20
About Prana Biotechnology
View Profile
